Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Journal of Molecular Medicine (Berlin, Germany)
|
July 3, 2017
The impact of structural biology in medicine illustrated with four case studies
Tiancen Hu, Elizabeth R Sprague, Michelle Fodor, et al.
Nature Communications
|
October 31, 2018
Structural reorganization of SHP2 by oncogenic mutations and implications for oncoprotein resistance to allosteric inhibition
Jonathan R LaRochelle, Michelle Fodor, Vidyasiri Vemulapalli, et al.
Bioorganic & Medicinal Chemistry
|
November 2, 2017
Identification of an allosteric benzothiazolopyrimidone inhibitor of the oncogenic protein tyrosine phosphatase SHP2
Jonathan R LaRochelle, Michelle Fodor, Jana M Ellegast, et al.
Biochemistry
|
April 1, 2016
Structural and Functional Consequences of Three Cancer-Associated Mutations of the Oncogenic Phosphatase SHP2
Jonathan R LaRochelle, Michelle Fodor, Xiang Xu, et al.
Journal of Applied Crystallography
|
August 25, 2021
A capillary-based microfluidic device enables primary high-throughput room-temperature crystallographic screening
Shuo Sui, Anne Mulichak, Raviraj Kulathila, et al.
Elife
|
May 17, 2016
ERG signaling in prostate cancer is driven through PRMT5-dependent methylation of the Androgen Receptor
Zineb Mounir, Joshua M Korn, Thomas Westerling, et al.
Nature
|
July 13, 2022
Structure of the MRAS-SHOC2-PP1C phosphatase complex
Zachary J Hauseman, Michelle Fodor, Anxhela Dhembi, et al.
Journal of Medicinal Chemistry
|
January 29, 2019
Optimization of Fused Bicyclic Allosteric SHP2 Inhibitors
Jeffrey T Bagdanoff, Zhouliang Chen, Michael Acker, et al.
ACS Chemical Biology
|
January 6, 2018
Dual Allosteric Inhibition of SHP2 Phosphatase
Michelle Fodor, Edmund Price, Ping Wang, et al.
Journal of Medicinal Chemistry
|
January 29, 2019
6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 Inhibitors
Patrick Sarver, Michael Acker, Jeffrey T Bagdanoff, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Journal of Molecular Medicine (Berlin, Germany)
|
July 3, 2017
The impact of structural biology in medicine illustrated with four case studies
Tiancen Hu, Elizabeth R Sprague, Michelle Fodor, et al.
Nature Communications
|
October 31, 2018
Structural reorganization of SHP2 by oncogenic mutations and implications for oncoprotein resistance to allosteric inhibition
Jonathan R LaRochelle, Michelle Fodor, Vidyasiri Vemulapalli, et al.
Bioorganic & Medicinal Chemistry
|
November 2, 2017
Identification of an allosteric benzothiazolopyrimidone inhibitor of the oncogenic protein tyrosine phosphatase SHP2
Jonathan R LaRochelle, Michelle Fodor, Jana M Ellegast, et al.
Biochemistry
|
April 1, 2016
Structural and Functional Consequences of Three Cancer-Associated Mutations of the Oncogenic Phosphatase SHP2
Jonathan R LaRochelle, Michelle Fodor, Xiang Xu, et al.
Journal of Applied Crystallography
|
August 25, 2021
A capillary-based microfluidic device enables primary high-throughput room-temperature crystallographic screening
Shuo Sui, Anne Mulichak, Raviraj Kulathila, et al.
Elife
|
May 17, 2016
ERG signaling in prostate cancer is driven through PRMT5-dependent methylation of the Androgen Receptor
Zineb Mounir, Joshua M Korn, Thomas Westerling, et al.
Nature
|
July 13, 2022
Structure of the MRAS-SHOC2-PP1C phosphatase complex
Zachary J Hauseman, Michelle Fodor, Anxhela Dhembi, et al.
Journal of Medicinal Chemistry
|
January 29, 2019
Optimization of Fused Bicyclic Allosteric SHP2 Inhibitors
Jeffrey T Bagdanoff, Zhouliang Chen, Michael Acker, et al.
ACS Chemical Biology
|
January 6, 2018
Dual Allosteric Inhibition of SHP2 Phosphatase
Michelle Fodor, Edmund Price, Ping Wang, et al.
Journal of Medicinal Chemistry
|
January 29, 2019
6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 Inhibitors
Patrick Sarver, Michael Acker, Jeffrey T Bagdanoff, et al.
Page
of 2